Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Therapeutic Drug Monitoring
|
June 17, 2016
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection
Prajakta S Badri, Apurvasena Parikh, Eoin P Coakley, et al.
Clinical Pharmacology and Therapeutics
|
May 8, 2023
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials
Lubna Abuqayyas, Po-Wei Chen, Marcia Teixeira Dos Santos, et al.
Clinical Pharmacokinetics
|
March 23, 2016
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies
Akshanth R Polepally, Sven Mensing, Amit Khatri, et al.
Journal of Clinical Pharmacology
|
May 7, 2016
Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT-981 Against IL-1α and IL-1β in Healthy Subjects and Patients With Osteoarthritis of the Knee
Matthew P Kosloski, Sandra Goss, Susanne X Wang, et al.
Journal of Clinical Pharmacology
|
September 11, 2023
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Di Zhou, Lauren A Byers, Beate Sable, et al.
Clinical Drug Investigation
|
June 7, 2021
Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects
Ashit Trivedi, Rajneet K Oberoi, Pegah Jafarinasabian, et al.
Clinical and Translational Science
|
June 9, 2022
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development
Johannes Kast, Saeideh Nozohouri, Di Zhou, et al.
Epilepsia
|
February 27, 2007
Safety of rapid intravenous loading of valproate
Nita A Limdi, Robert K Knowlton, Stacey S Cofield, et al.
Clinical Therapeutics
|
October 28, 2015
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects
Jiuhong Zha, Prajakta S Badri, Bifeng Ding, et al.
Clinical Pharmacokinetics
|
July 9, 2016
Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment
Amit Khatri, Sandeep Dutta, Thomas C Marbury, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Therapeutic Drug Monitoring
|
June 17, 2016
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection
Prajakta S Badri, Apurvasena Parikh, Eoin P Coakley, et al.
Clinical Pharmacology and Therapeutics
|
May 8, 2023
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials
Lubna Abuqayyas, Po-Wei Chen, Marcia Teixeira Dos Santos, et al.
Clinical Pharmacokinetics
|
March 23, 2016
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies
Akshanth R Polepally, Sven Mensing, Amit Khatri, et al.
Journal of Clinical Pharmacology
|
May 7, 2016
Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT-981 Against IL-1α and IL-1β in Healthy Subjects and Patients With Osteoarthritis of the Knee
Matthew P Kosloski, Sandra Goss, Susanne X Wang, et al.
Journal of Clinical Pharmacology
|
September 11, 2023
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Di Zhou, Lauren A Byers, Beate Sable, et al.
Clinical Drug Investigation
|
June 7, 2021
Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects
Ashit Trivedi, Rajneet K Oberoi, Pegah Jafarinasabian, et al.
Clinical and Translational Science
|
June 9, 2022
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development
Johannes Kast, Saeideh Nozohouri, Di Zhou, et al.
Epilepsia
|
February 27, 2007
Safety of rapid intravenous loading of valproate
Nita A Limdi, Robert K Knowlton, Stacey S Cofield, et al.
Clinical Therapeutics
|
October 28, 2015
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects
Jiuhong Zha, Prajakta S Badri, Bifeng Ding, et al.
Clinical Pharmacokinetics
|
July 9, 2016
Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment
Amit Khatri, Sandeep Dutta, Thomas C Marbury, et al.
Page
of 12